Theranostics 2017; 7(8):2287-2288. doi:10.7150/thno.19286

Commentary

Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis

Zhongxiu Chen1*, Yajiao Li1*, Ke Dian2, Li Rao1✉

1. Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China;
2. Department of Cardiovascular Surgery, West China Hospital of Sichuan University, Chengdu, China.
* These two authors contributed equally to this work.

Abstract

This commentary highlights the findings by Tao et al. (Theranostics 2016; 6: 2068-2083) that targeting miR-433 may be a potential therapeutic strategy for myocardial fibrosis and subsequently discusses the obstacles and prospects associated with the application of therapeutic microRNAs in anti-fibrosis treatment.

Keywords: Cardiac fibrosis, microRNAs, Therapeutic targets.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Chen Z, Li Y, Dian K, Rao L. Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis. Theranostics 2017; 7(8):2287-2288. doi:10.7150/thno.19286. Available from http://www.thno.org/v07p2287.htm